Pennant Capital Management LLC Has Decreased Its Stake in Nxstage Medical INC (NXTM) by $6.76 Million as Stock Value Rose

June 17, 2018 - By Dolores Ford

Nxstage Medical, Inc. (NASDAQ:NXTM) LogoInvestors sentiment decreased to 1.1 in Q1 2018. Its down 0.15, from 1.25 in 2017Q4. It dived, as 15 investors sold NXTM shares while 45 reduced holdings. 15 funds opened positions while 51 raised stakes. 48.16 million shares or 0.80% more from 47.78 million shares in 2017Q4 were reported. Polar Asset Management stated it has 0.08% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM). Ameritas Inv Ptnrs Inc owns 5,498 shares. Senzar Asset Ltd holds 1.64% or 208,480 shares. Quantbot Technology LP stated it has 8,570 shares. Capstone Investment Advisors Lc holds 0.1% or 201,760 shares in its portfolio. Royal Commercial Bank Of Canada invested in 0% or 3,069 shares. Magnetar Fincl Limited Liability Company has 3.06 million shares. Hsbc Plc owns 221,269 shares. Qs Investors Lc owns 94,362 shares or 0.02% of their US portfolio. Moreover, Indexiq Advsrs Ltd Llc has 0.15% invested in Nxstage Medical, Inc. (NASDAQ:NXTM). Water Island Capital Lc accumulated 1.18% or 1.18M shares. Jpmorgan Chase & invested in 0.01% or 1.44M shares. Employees Retirement Association Of Colorado holds 0% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM) for 5,273 shares. Jefferies Grp Incorporated Limited Liability Com holds 0% in Nxstage Medical, Inc. (NASDAQ:NXTM) or 13,866 shares. 114 are owned by Pnc Financial Ser Group Inc Inc.

Since January 16, 2018, it had 0 insider buys, and 2 sales for $172,760 activity.

Alan Fournier decreased its stake in Nxstage Medical Inc (NXTM) by 16.05% based on its latest 2018Q1 regulatory filing with the SEC. Pennant Capital Management Llc sold 281,830 shares as the company’s stock rose 13.63% while stock markets declined. The hedge fund run by Alan Fournier held 1.47M shares of the health care company at the end of 2018Q1, valued at $36.66 million, down from 1.76M at the end of the previous reported quarter. Pennant Capital Management Llc who had been investing in Nxstage Medical Inc for a number of months, seems to be less bullish one the $1.89 billion market cap company. The stock decreased 0.42% or $0.12 during the last trading session, reaching $28.36. About 240,190 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has risen 20.76% since June 17, 2017 and is uptrending. It has outperformed by 8.19% the S&P500.

Analysts await Nxstage Medical, Inc. (NASDAQ:NXTM) to report earnings on August, 6. They expect $-0.02 earnings per share, up 33.33 % or $0.01 from last year’s $-0.03 per share. After $-0.02 actual earnings per share reported by Nxstage Medical, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Nxstage Medical, Inc. (NASDAQ:NXTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.